Acadia Healthcare Company, Inc.
ACHCNasdaqHealthcare · Services-Specialty Outpatient Facilities, NEC · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $3.31B | $3.15B | $2.93B | $2.61B | $2.31B | $2.09B |
| Operating income | — | — | — | — | — | — |
| Net income | −$1.10B | $255.6M | −$21.7M | $273.1M | $190.6M | −$672.1M |
| Total assets | $5.53B | $5.96B | $5.36B | $4.99B | $4.77B | $6.50B |
| Total liabilities | $3.39B | $2.77B | $2.47B | $2.09B | $2.19B | $4.54B |
| Equity | $1.95B | $3.07B | $2.78B | $2.81B | $2.52B | $1.90B |
| EPS (diluted) | $-12.16 | $2.78 | $-0.24 | $2.98 | $2.10 | $-7.59 |
| Shares out. | 92.9M | 92.3M | 91.3M | 89.9M | 89.0M | 88.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- −33.3%
- Return on equity
- −56.6%
- Return on assets
- −20.0%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 61.3%
- Debt / equity
- 1.74×
- Book value / share
- $20.98
- Revenue growth (YoY)
- 5.0%
- Net income growth (YoY)
- −531.4%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −22.3%clean
- Piotroski F-Score
- 4/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 3 good- Reported a net loss
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Khrom Investments Fund, LpActivist (13D)May 15, 2026
- Wellington Management Group LlpPassive (13G)May 15, 2026
- Goldman Sachs Group IncPassive (13G)May 11, 2026
- Vanguard Capital Management LlcPassive (13G)Apr 29, 2026
- Vanguard Portfolio Management LlcPassive (13G)Apr 28, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- Blackrock, Inc.Passive (13G)Oct 2, 2025
- T. Rowe Price Investment Management, Inc.Passive (13G)May 14, 2025
- Fmr LlcPassive (13G)Feb 12, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 22.6M | 8.2 | -5.0% |
| Apr 30, 2026 | 23.8M | 6.9 | +7.7% |
| Apr 15, 2026 | 22.1M | 7.9 | +0.3% |
| Mar 31, 2026 | 22.1M | 7.7 | -11.9% |
| Mar 13, 2026 | 25.1M | 7.5 | -9.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Other material eventMay 18, 2026
- Shareholder voteMay 6, 2026
- Results of operations · Regulation FD disclosureApr 29, 2026
- Director / officer change · Regulation FD disclosureApr 23, 2026
- Director / officer change · Regulation FD disclosureMar 12, 2026
- Results of operations · Regulation FD disclosureFeb 25, 2026
- Director / officer changeJan 23, 2026
- Director / officer change · Regulation FD disclosureJan 20, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KMay 18, 2026
- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- S-8May 11, 2026
- 3May 11, 2026
- SCHEDULE 13G/AMay 11, 2026
- 4May 8, 2026
- 4May 8, 2026
- 4May 8, 2026
- 4May 8, 2026
- 4May 8, 2026
- 4May 8, 2026
- 4May 8, 2026
- 4May 8, 2026
- 4May 8, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.